Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants

American Journal of Perinatology

Volumn 14, Issue 5, 1997, Pages 303-307

  FineSmith, Ross B ^a,c   Roche, Kevin ^a   Yellin, Paul B ^a   Walsh, Kevin K ^b   Shen, Calvin ^b   Zeglis, Mark ^d   Kahn, Atiya ^a   Fish, Irving ^a  

^a NEW YORK UNIVERSITY   (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

cerebral palsy; magnesium sulfate; neuroprotection; Periventricular leukomalacia; preterm infants; preterm labor

Indexed keywords

MAGNESIUM SULFATE;

ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; INFANT; LEUKOMALACIA; NEUROPROTECTION; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL;

EID: 0031002812     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994149     Document Type: Article

References (38)

1. Guyer B, Strobino DM, Venttura SJ, Singh GK. Annual summary of vital statistics - 1994. Pediatrics 1995;96:1029-39
2. Wagner ME. Annual summary of statistics - 1993. Pediatrics 1995;94:792-803
3. Horbar JD, McHuliffe TL, Adler SM, Albersheim S, Cassady G, Edwards W, Jones R, Kaftwinkel J, Kraybill EN, Krishnan V, Raschko P, Wilkinson AR. Variability in 28 day outcomes for very low birthweight infants: An analysis of 11 neonatal intensive care units. Pediatrics 1988;82:554-59
4. Hagberg B, Hagberg G, Olow I. The changing panorama of cerebral palsy in Sweden. Acta Paediatr Scand 1984;73: 433-400
5. Pharoah PD, Cooke T, Rosenbloom I, Cooke RI. Trends in birth prevalence of cerebral palsy. Arch Dis Child 1987;2: 379-84
6. Hagberg B, Hagberg G, Zetterstrom R. Decreasing perinatal mortality - Increase in cerebral palsy morbidity. Acta Paediatr Scand 1989;78:664
7. Krudrjavcev T, Schoenberg BS, Kurland LT, Groover, RV Cerebral palsy - Trends in incidence and changes in concurrent neonatal mortality: Rochester, MN, 1950-1976. Neurology 1983;33:1433-8
8. Naulty C, Long L, Pettett G. Prevalence of prematurity, low birth weight, and asphyxia as perinatal risk factors in a current population of children with cerebral palsy. Am J Perinatol 1994;11:377-81
9. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. I. Univariate analysis of risk. Am J Dis Child 1985;139:1031-8
10. Banker BQ, Larroche JC. Periventricular leukomalacia of infancy: A form of neonatal anoxic encephalopathy. Arch Neurol 1962;7:386-410
11. de Vries L, Levene M. Cerebral ischemic lesions. In Levene M, Lilford R, eds. Fetal and Neonatal Neurology and Neurosurgery. London: Churchill Livingstone; 1995:323
12. Young RS, Hernandez MJ, Yagel SK. Selective reduction of blood flow to white matter during hypotension in newborn dogs: A possible mechanism of periventricular leukomalacia. Ann Neurol 1982;12:445-8
13. Duffy TE, Cavazzuti M, Cruz NF, Sokoloff L. Local cerebral glucose metabolism in newborn dogs: Effects of hypoxia and halothane anesthesia. Ann Neurol 1982;11:233-46
14. Cavazzuti M, Duffy TE. Regulation of local cerebral blood flow in normal and hypoxic newborn dogs. Ann Neurol 1982;11:247-57
15. Takashima S, Tanaka K. Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol 1978;35:11-16
16. Volpe, JJ. Neurology of the Newborn. Philadelphia: Saunders; 1994:296-9
17. de Vries LS, Eken P, Groendaal F, van Haastert IC, Meiners LC. Correlation between the degree of periventricular leukomalacia diagnosed using cranial ultrasound and MRI later in infancy in children with cerebral palsy. Neuropediatrics 1993;24:263-9
18. Rodgers B, Msall M, Owens T, Guernsey K, Brody K, Buck G, Hudak M. Cystic periventricular leukomalacia and type of cerebral palsy in preterm infants. J Pediatr 1994;124:S1-8
19. Fujimoto S, Yamaguchi N, Togari H, Wada Y, Yokochi K. Cerebral palsy of cystic periventricular leukomalacia in low-birth-weight infants. Acta Paediatrica 1994;83:397-401
20. Pidcock FS, Graziani LJ, Stanley C, Mitchell DG, Merton P. Neurosonographic features of periventricular echodensities associated with cerebral palsy in preterm infants. J Pediatr 1990;116:417-22
21. Powell TG, Pharoah PD, Cooke RI, Rosenbloom L. Cerebral palsy in low-birthweight infants. II. Spastic diplegia: Associations with intrapartum stress. Dev Med Child Neurol 1988; 30:19-25
22. Powell TG, Pharoah PD, Cooke, RI, Rosenbloom L. Cerebral palsy in low-birthweight infants. I. Spastic hemiplegia: Associations with intrapartum stress. Dev Med Child Neurol 1988;30:11-18
23. Nelson KB, Ellenberg JH. Neonatal signs as predictors of cerebral palsy. Pediatrics 1979;64:225-32
24. Naeye RL, Peters EC, Bartholomew M, Landis B. Origins of cerebral palsy. Am J Dis Child 1989;143:1154-61
25. Boyle CA, Decoufle P, Yeargin-Allsopp M. Prevalence and health impact of developmental disabilities in US children. Pediatrics 1994;93:399-403
26. Murphy CC, Yeargin-Allsopp M, Decoufle P, Drews CD. Prevalence of cerebral palsy among ten-year-old children in metropolitan Atlanta, 1985 through 1987. J Pediatr 1993; 123:513-20
27. Stanley FJ. Spastic cerebral palsy: Changes in birthweight and gestational age. Early Hum Dev 1981;51:167-78
28. McDonald AD. Cerebral palsy in children of very low birth weight. Arch Dis Child 1963;38:579
29. Jarvis S, Holloway J, Hey E. Increase in cerebral palsy in normal birthweight babies. Arch Dis Child 1985;60:1113-21
30. Nelson KB, Grether JK. Can magnsium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:263-9
31. Ames A, Nesbett AM. Pathophysiology of ischemic cell death: I. Time of onset of irreversible damage; Importance of the different components of the ischemic insult. Stroke 1983;14:219-26
32. Izumi Y, Roussel S, Pinard E, Seylaz J. Reduction of infarct volume by magnesium sulfate after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991;11:1025-30
33. Schmitt H, Barth G, Thierauf P. Neuronal protection by ischemic brain perfusion: An electron microscopy study in the rat. J Neurosurg Anesthesiol 1994;6:265-74
34. Marret S, Gressens P Gadisseux J, Evrard P. Prevention by magnesium of exitotoxic neuronal death in the developing brain: An animal model for clinical intervention studies. Dev Med Child Neurol 1995;37:473-84
35. Thordstein M, Bagenholm R, Thringer K, Kjellmer I. Scavengers of free oxygen radicals in combination with magnesium ameliorate perinatal hypoxic-ischemic brain damage in the rat. Pediatr Res 1993;34:23-6
36. McDonald JW, Silverstein FS, Johnston MV. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett 1990;109:234-8
37. McDonald HM, Mulligan, JC, Allen AC, Taylor PM. Neonatal asphyxia. I. Relationship of obstetric and neonatal complications to neonatal mortality in 38,405 consecutive deliveries. J Pediatr 1980;96:898-902
38. Nelson KB, Ellenberg, JH. Antecedents of cerebral palsy. Multivariate analysis of risk. NEJM 1986;315:81-6